Soo-Hyun Kim

This inventor holds 6 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 3 EPO patents. Top assignees: Ares Trading S.a., University of Colorado, Yeda Research and Develpment & Co. Ltd. Active years: 2007-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Soo-Hyun Kim. Retrieved from https://idiyas.com/inventor/soo-hyun-kim-axebparb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 6 (Patent Applications = 1)

% Patents Active = 16.7

CIPO Patents = 2

EPO Patents = 3 (Patent Applications = 1)

Average Co-Inventor Count = 2.9

ph-index = 2

Forward Citations = 14(Granted Patents)

Location History:

Greenwood Village City, CO (US) (2011)
Aurora, CO (US) (2007 - 2015)

Company Filing History:

University of Colorado

patents

1 out of 1,168

Yeda Research and Develpment & Co. Ltd

patents

where one patent can have more than one assignee

Years Active: 2007-2015

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9045559 - Method for screening inhibitors of interleukin-32 (IL-32) (2015-06-02),

2. 8138312 - Compositions for regulation of tumor necrosis factor-alpha (2012-03-20),

3. 7875709 - Nucleic acids encoding interleukin-18 mutants (2011-01-25),

4. 7820156 - Method of treatment using a cytokine able to bind IL-18BP to inhibit the activity of a second cytokine (2010-10-26),

5. 7560265 - Compositions for regulation of tumor necrosis factor-alpha (2009-07-14),

6. 7279155 - Method of treatment using a cytokine able to bind IL-18BP to inhibit the activity of a second cytokine (2007-10-09),

Title: The Innovative Contributions of Inventor Soo-Hyun Kim

Introduction

Soo-Hyun Kim is a prominent inventor based in Aurora, CO (US). She has made significant contributions to the field of biomedical research, particularly in the area of cytokine modulation. With a total of 6 patents to her name, her work has the potential to impact the treatment of various autoimmune diseases and cancer.

Latest Patents

Among her latest patents is a method for screening inhibitors of interleukin-32 (IL-32). This invention relates to methods of identifying modulators of IL-32 and their applications. Another notable patent involves compositions for the regulation of tumor necrosis factor-alpha. This invention provides methods and compositions for treating autoimmune diseases and cancer by regulating the expression of tumor necrosis factor-alpha.

Career Highlights

Soo-Hyun Kim has worked with notable organizations, including Ares Trading S.a. and the University of Colorado. Her career reflects a commitment to advancing scientific knowledge and developing innovative solutions in her field.

Collaborations

Some of her notable coworkers include Charles A. Dinarello and Philip Bufler. Their collaborative efforts have contributed to the advancement of research in cytokine modulation.

Conclusion

Soo-Hyun Kim's innovative work and patents demonstrate her significant impact on biomedical research. Her contributions continue to pave the way for new treatments in the medical field.

Profile summary based on public USPTO records.